{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:55:37Z","timestamp":1779317737199,"version":"3.51.4"},"reference-count":39,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lipidology"],"published-print":{"date-parts":[[2015,8,1]]},"DOI":"10.2217\/clp.15.23","type":"journal-article","created":{"date-parts":[[2015,8,19]],"date-time":"2015-08-19T13:34:55Z","timestamp":1439991295000},"page":"305-312","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":24,"title":["Management of lipoprotein X and its complications in a patient with primary sclerosing cholangitis"],"prefix":"10.1080","volume":"10","author":[{"given":"Eric J","family":"Brandt","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Chicago, Chicago, IL, 60637, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shane M","family":"Regnier","sequence":"additional","affiliation":[{"name":"Pritzker School of Medicine, University of Chicago, Chicago, IL 60637, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward Ky","family":"Leung","sequence":"additional","affiliation":[{"name":"Pritzker School of Medicine, University of Chicago, Chicago, IL 60637, USA"},{"name":"Department of Pathology, University of Chicago, Chicago, IL, 60637, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon H","family":"Chou","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Chicago, Chicago, IL, 60637, USA"},{"name":"Section of Endocrinology, Diabetes & Metabolism, University of Chicago, Chicago, IL, 60637, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly W","family":"Baron","sequence":"additional","affiliation":[{"name":"Pritzker School of Medicine, University of Chicago, Chicago, IL 60637, USA"},{"name":"Department of Pathology, University of Chicago, Chicago, IL, 60637, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen S","family":"Te","sequence":"additional","affiliation":[{"name":"Pritzker School of Medicine, University of Chicago, Chicago, IL 60637, USA"},{"name":"Section of Gastroenterology, University of Chicago, Chicago, IL, 60637, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H","family":"Davidson","sequence":"additional","affiliation":[{"name":"Pritzker School of Medicine, University of Chicago, Chicago, IL 60637, USA"},{"name":"Section of Cardiology, University of Chicago, Chicago, IL, 60637, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M","family":"Sargis","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Chicago, Chicago, IL, 60637, USA"},{"name":"Pritzker School of Medicine, University of Chicago, Chicago, IL 60637, USA"},{"name":"Section of Endocrinology, Diabetes & Metabolism, University of Chicago, Chicago, IL, 60637, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,1,18]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","unstructured":"Ahrens EH, Kunkel HG. The relationship between serum lipids and skin xanthomata in eighteen patients with primary biliary cirrhosis. J. Clin. Invest. 28(6 pt 2), 1565\u20131574 (1949).","DOI":"10.1172\/JCI102222"},{"key":"CIT0002","doi-asserted-by":"crossref","unstructured":"Kunkel HG, Ahrens EJ. The relationship between serum lipids and the electrophoretic pattern, with particular reference to patients with primary biliary cirrhosis. J. Clin. Invest. 28(6 pt 2), 1575\u20131579 (1949).","DOI":"10.1172\/JCI102223"},{"key":"CIT0003","doi-asserted-by":"crossref","unstructured":"Seidel D, Alaupovic P, Furman R. A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects. J. Clin. Invest. 48(7), 1211\u20131223 (1969). \u2022 Describes The Isolation Of A Unique Fraction Of Ldl From The Plasma Of Patients With Biliary Obstruction And Coins The Term Lipoprotein X (Lpx).","DOI":"10.1172\/JCI106085"},{"key":"CIT0004","doi-asserted-by":"crossref","unstructured":"Seidel D, Alaupovic P, Furman R, McConathy W. A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins. J. Clin. Invest. 49(12), 2396\u20132407 (1970).","DOI":"10.1172\/JCI106459"},{"key":"CIT0005","doi-asserted-by":"crossref","unstructured":"Torsvik H, Berg K, Magnani HN, McConathy WJ, Alaupovic P, Gjone E. Identification of the abnormal cholestatic lipoprotein (LP-X) in familial lecithin: cholesterol acyltransferase deficiency. FEBS Lett. 24(2), 165\u2013168 (1972).","DOI":"10.1016\/0014-5793(72)80758-0"},{"key":"CIT0006","doi-asserted-by":"crossref","unstructured":"Turchin A, Wiebe DA, Seely EW, Graham T, Longo W, Soiffer R. Severe hypercholesterolemia mediated by lipoprotein X in patients with chronic graft-versus-host disease of the liver. Bone Marrow Transpl. 35(1), 85\u201389 (2005).","DOI":"10.1038\/sj.bmt.1704739"},{"key":"CIT0007","doi-asserted-by":"crossref","unstructured":"Samsioe G, Johnson P, Gustafson A. Studies in cholestasis of pregnancy. VI. Fatty acid composition of glycerophospholipids before and after delivery. Acta Obstet. Gynecol. Scand. 56(1), 31\u201335 (1977).","DOI":"10.3109\/00016347709158336"},{"key":"CIT0008","doi-asserted-by":"crossref","unstructured":"Seidel D. Lipoproteins in liver disease. J. Clin. Biochem. 25(9), 541\u2013551 (1987).","DOI":"10.1515\/cclm.1987.25.9.541"},{"key":"CIT0009","doi-asserted-by":"crossref","unstructured":"S\u00f6r\u00f6s P, B\u00f6ttcher J, Maschek H, Selberg O, M\u00fcller MJ. Lipoprotein-X in patients with cirrhosis: its relationship to cholestasis and hypercholesterolemia. Hepatology 28(5), 1199\u20131205 (1998).","DOI":"10.1002\/hep.510280506"},{"key":"CIT0010","doi-asserted-by":"crossref","unstructured":"Nakamura Y, Kotite L, Gan Y, Spencer TA, Fielding CJ, Fielding PE. Molecular mechanism of reverse cholesterol transport: reaction of pre-beta-migrating high-density lipoprotein with plasma lecithin\/cholesterol acyltransferase. Biochemistry 43(46), 14811\u201314820 (2004).","DOI":"10.1021\/bi0485629"},{"key":"CIT0011","doi-asserted-by":"crossref","unstructured":"Jonas A. Lecithin cholesterol acyltransferase. Biochim. Biophys. Acta 1529(1\u20133), 245\u2013256 (2000).","DOI":"10.1016\/S1388-1981(00)00153-0"},{"key":"CIT0012","doi-asserted-by":"crossref","unstructured":"Kuivenhoven JA, van Voorst tot Voorst EJ, Wiebusch H et al. A unique genetic and biochemical presentation of fish-eye disease. J. Clin. Invest. 96(6), 2783\u20132791 (1995).","DOI":"10.1172\/JCI118348"},{"key":"CIT0013","doi-asserted-by":"crossref","unstructured":"Norum KR, Gjone E. Familial serum-cholesterol esterification failure. A new inborn error of metabolism. Biochim. Biophys. Acta 144(3), 698\u2013700 (1967).","DOI":"10.1016\/0005-2760(67)90064-1"},{"key":"CIT0014","unstructured":"Saeedi R, Li M, Frohlich J. A review on lecithin:cholesterol acyltransferase deficiency. Clin. Biochem. 48(7\u20138), 474\u2013475 (2014). \u2022 Provides An Excellent Review Of Lecithin:Cholesterol Acyltransferase Deficiency, Which Is To Be Included Within The Differential Diagnosis For Lpx Accumulation."},{"key":"CIT0015","doi-asserted-by":"crossref","unstructured":"Liersch M, Baggio G, Heuck CC, Seidel D. Effect of lipoprotein-X on hepatic cholesterol synthesis. Atherosclerosis 26(4), 505\u2013514 (1977).","DOI":"10.1016\/0021-9150(77)90118-6"},{"key":"CIT0016","doi-asserted-by":"crossref","unstructured":"Ross A, Murphy GM, Wilkinson PA, Mills GL, Sherlock S. Occurrence of an abnormal lipoprotein in patients with liver disease. Gut 11(12), 1035\u20131037 (1970).","DOI":"10.1136\/gut.11.12.1035"},{"key":"CIT0017","doi-asserted-by":"crossref","unstructured":"Jorgensen RA, Lindor KD, Sartin JS, LaRusso NF, Wiesner RH. Serum lipid and fat-soluble vitamin levels in primary sclerosing cholangitis. J. Clin. Gastroenterol. 20(3), 215\u2013219 (1995).","DOI":"10.1097\/00004836-199504000-00011"},{"key":"CIT0018","doi-asserted-by":"crossref","unstructured":"Sivakumar T, Chaidarun S, Lee HK, Cervinski M, Comi R. Multiple lipoprotein and electrolyte laboratory artifacts caused by lipoprotein X in obstructive biliary cholestasis secondary to pancreatic cancer. J. Clin. Lipidol. 5(4), 324\u2013328 (2011).","DOI":"10.1016\/j.jacl.2011.04.004"},{"key":"CIT0019","doi-asserted-by":"crossref","unstructured":"Rosenson R, Baker A, Chow M, Hay R. Hyperviscosity syndrome in a hypercholesterolemic patient with primary biliary cirrhosis. Gastroenterology 98(5 pt 1), 1351\u20131357 (1990).","DOI":"10.1016\/0016-5085(90)90356-6"},{"key":"CIT0020","unstructured":"Narayanan S. Biochemistry and clinical relevance of lipoprotein X. Ann. Clin. Lab. Sci. 14(5), 371\u2013374 (1984)."},{"key":"CIT0021","unstructured":"Appel G, Radhakrishnan J, D\u2019agati V. Lecithin-cholesterol acyltransferase deficiency. In: Brenner and Rector\u2019s The Kidney. Taal M, Chertow G, Marsden C, Shorecki K, Yu A, Brenner B (Eds). Elsevier, Inc., PA, USA, 1245\u20131246 (2012)."},{"key":"CIT0022","doi-asserted-by":"crossref","unstructured":"Chang P, Lu S, Su T et al. Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation. J. Lipid Res. 45(11), 2116\u20132122 (2004).","DOI":"10.1194\/jlr.M400229-JLR200"},{"key":"CIT0023","unstructured":"Ooi Y, Mietus-Snyder M, Torres C, Mohan P, Harahsheh A. Lipoprotein-X accumulation: a mimic of familial hypercholesterolemia. Consultant 53(5), 304\u2013308 (2013)."},{"key":"CIT0024","doi-asserted-by":"crossref","unstructured":"Franceschini G, Busnach G, Chiesa G, Sirtori C. Management of lipoprotein-X accumulation in severe cholestasis by semi-selective LDL-apheresis. Am. J. Med. 90(5), 633\u20138 (1991). \u2022\u2022 This Is The First Report Of The Use Of Semi-Selective Apheresis Techniques To Manage A Patient With Primary Sclerosing Cholangitis And Lpx Dyslipidemia With Severe Xanthomas.","DOI":"10.1016\/S0002-9343(05)80018-X"},{"key":"CIT0025","doi-asserted-by":"crossref","unstructured":"Gandelman G, Aronow WS, Weiss MB. Resolving hyperlipidemia after liver transplantation in a patient with primary sclerosing cholangitis. Am. J. Ther. 13(2), 171\u2013174 (2006).","DOI":"10.1097\/00045391-200603000-00014"},{"key":"CIT0026","doi-asserted-by":"crossref","unstructured":"Takata K, Kajiyama G, Horiuchi I, Watanabe T, Tokumo H, Hirata Y. A new case of familial lecithin: cholesterol acyltransferase (LCAT) deficiency \u2013 paradoxical findings regarding LCAT mass and activity in 23 members of a family. Jpn. J. Med. 28(6), 765\u2013771 (1989).","DOI":"10.2169\/internalmedicine1962.28.765"},{"key":"CIT0027","doi-asserted-by":"crossref","unstructured":"Naito S, Kamata M, Furuya M et al. Amelioration of circulating lipoprotein profile and proteinuria in a patient with LCAT deficiency due to a novel mutation (Cys74Tyr) in the lid region of LCAT under a fat-restricted diet and ARB treatment. Atherosclerosis 228(1), 193\u2013197 (2013).","DOI":"10.1016\/j.atherosclerosis.2013.02.034"},{"key":"CIT0028","doi-asserted-by":"crossref","unstructured":"Simonelli S, Tinti C, Salvini L et al. Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency. Biologicals 41(6), 446\u2013449 (2013).","DOI":"10.1016\/j.biologicals.2013.09.007"},{"key":"CIT0029","doi-asserted-by":"crossref","unstructured":"Abu Rajab M, Kaplan MM. Statins in primary biliary cirrhosis: are they safe? Dig. Dis. Sci. 55(7), 2086\u20132088 (2010). \u2022\u2022 Reports Safety And Tolerance Of Multiple Statins In Patients With Cholestasis Due To Primary Biliary Cirrhosis.","DOI":"10.1007\/s10620-009-0988-9"},{"key":"CIT0030","doi-asserted-by":"crossref","unstructured":"Stojakovic T, Claudel T, Putz-Bankuti C et al. Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment. Atherosclerosis 209(1), 178\u2013183 (2010).","DOI":"10.1016\/j.atherosclerosis.2009.08.052"},{"key":"CIT0031","doi-asserted-by":"crossref","unstructured":"Cash WJ, O\u2019Neill S, O\u2019Donnell ME et al. Randomized controlleed trial assessing the effect of simvastatin in primary biliary cirrhosis. Liver Int. 33(8), 1166\u20131174 (2013).","DOI":"10.1111\/liv.12191"},{"key":"CIT0032","doi-asserted-by":"crossref","unstructured":"Del Puppo M, Galli Kienle M, Crosignani A et al. Cholesterol metabolism in primary biliary cirrhosis during simvastatin and UDCA administration. J. Lipid Res. 42(3), 437\u2013441 (2001). \u2022 Reports The Efficacy Of Simvastatin At Effectively Reducing Total Cholesterol Levels In Patients With Primary Biliary Cirrhosis.","DOI":"10.1016\/S0022-2275(20)31668-0"},{"key":"CIT0033","doi-asserted-by":"crossref","unstructured":"Bravo I, Amigo L, Cohen DE et al. Role of plasma and liver cholesterol- and lipoprotein-metabolism determinants in LpX formation in the mouse. Biochim. Biophys. Acta 1770(6), 979\u2013988 (2007).","DOI":"10.1016\/j.bbagen.2007.02.010"},{"key":"CIT0034","doi-asserted-by":"crossref","unstructured":"Miettinen TA, F\u00e4rkkil\u00e4 M, Vuoristo M et al. Serum cholestanol, cholesterol precursors, and plant sterols during placebo-controlled treatment of primary biliary cirrhosis with ursodeoxycholic acid or colchicine. Hepatology 21(5), 1261\u20131268 (1995).","DOI":"10.1002\/hep.1840210508"},{"key":"CIT0035","doi-asserted-by":"crossref","unstructured":"O\u2019Brien CB, Senior JR, Arora-Mirchandani R, Batta AK, Salen G. Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study. Hepatology 14(5), 838\u2013847 (1991).","DOI":"10.1002\/hep.1840140516"},{"key":"CIT0036","doi-asserted-by":"crossref","unstructured":"Sinakos E, Abbas G, Jorgensen RA, Lindor KD. Serum lipids in primary sclerosing cholangitis. Dig. Liver Dis. 44(1), 44\u201348 (2012).","DOI":"10.1016\/j.dld.2011.07.020"},{"key":"CIT0037","doi-asserted-by":"crossref","unstructured":"Poley J, Caplan D, Magnani H et al. Quantitative changes of serum lipoprotein-X after cholestyramine administration in infants with cholestatic biliary tract and liver disease. Eur. J. Clin. Invest. 8(6), 397\u2013404 (1978).","DOI":"10.1111\/j.1365-2362.1978.tb00871.x"},{"key":"CIT0038","doi-asserted-by":"crossref","unstructured":"Thannhauser SJ, Magendantz H. The different clinical groups of xanthomatous diseases; a clinical physiological study of 22 cases. Ann. Intern. Med. 11(9), 1662\u20131746 (1938).","DOI":"10.7326\/0003-4819-11-9-1662"},{"key":"CIT0039","doi-asserted-by":"crossref","unstructured":"Thannhauser S. Serum lipids and their value in diagnosis. N. Engl. J. Med. 237(14), 515\u2013522 (1947).","DOI":"10.1056\/NEJM194710022371405"}],"container-title":["Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/clp.15.23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T13:48:54Z","timestamp":1644328134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/clp.15.23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,1]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8,1]]}},"alternative-id":["10.2217\/clp.15.23"],"URL":"https:\/\/doi.org\/10.2217\/clp.15.23","relation":{},"ISSN":["1758-4299","1758-4302"],"issn-type":[{"value":"1758-4299","type":"print"},{"value":"1758-4302","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=tlip20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=tlip20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-01-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}